Palliative chemotherapy beyond three courses conveys no survival or consistent quality-of-life benefits in advanced non-small-cell lung cancer.

Autor: von Plessen, C.1 christian.von.plessen@helse-bergen.no, Bergman, B.2, Andresen, O.1, Bremnes, R. M.3,4, Sundstrøm, S.5, Gilleryd, M.2, Stephens, R.6, Vilsvik, J.7, Aasebø, U.8, Sörenson, S.1,9,10, Sundstrom, S (AUTHOR), Aasebo, U (AUTHOR), Sorenson, S (AUTHOR)
Zdroj: British Journal of Cancer. 10/23/2006, Vol. 95 Issue 8, p966-973. 8p. 4 Charts, 4 Graphs.
Databáze: Academic Search Ultimate